{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:20:38Z","timestamp":1783149638413,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08283"],"award-info":[{"award-number":["JP20K08283"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25460989"],"award-info":[{"award-number":["JP25460989"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154014","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:38:55Z","timestamp":1779550735000},"page":"154014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cilostazol inhibits TGF-\u03b1-induced migration of hepatocellular carcinoma cells by activating PPAR\u03b3"],"prefix":"10.1016","volume":"826","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7496-737X","authenticated-orcid":false,"given":"Rie","family":"Matsushima-Nishiwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4834-6073","authenticated-orcid":false,"given":"Osamu","family":"Kozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154014_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154014_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10360","key":"10.1016\/j.bbrc.2026.154014_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154014_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.4240\/wjgs.v13.i9.967","article-title":"Finding the seed of recurrence: hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment","volume":"12","author":"Carissimi","year":"2021","journal-title":"World J. Gastrointest. Surg."},{"key":"10.1016\/j.bbrc.2026.154014_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2009.12.034","article-title":"Cancer gene discovery in hepatocellular carcinoma","volume":"52","author":"Zender","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154014_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase-AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154014_bib7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.bbadis.2017.04.021","article-title":"Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)\/AKT pathway","volume":"1863","author":"Matsushima-Nishiwaki","year":"2017","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.bbrc.2026.154014_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108296","article-title":"Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-\u03b1: attenuation of AKT signaling pathway","volume":"682","author":"Yamada","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2026.154014_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10557-021-07187-x","article-title":"Cilostazol: a review of basic mechanisms and clinical uses","volume":"36","author":"Kherallah","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bbrc.2026.154014_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jcph.1988","article-title":"Update on cilostazol: a critical review of its antithrombotic and cardiovascular actions and its clinical applications","volume":"62","author":"Manolis","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154014_bib11","article-title":"Efficacy, safety, and role of antiplatelet drugs in the management of acute coronary syndrome: a comprehensive review of literature","volume":"15","author":"Abubakar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bbrc.2026.154014_bib12","series-title":"Cilostazol, Statpearls, Treasure Island","author":"Balinski","year":"2025"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154014_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0049-3848(83)90356-0","article-title":"Mechanism of action of dipyridamole","volume":"29","author":"Harker","year":"1983","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbrc.2026.154014_bib14","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","article-title":"Translational therapeutics of dipyridamole","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2026.154014_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jns.2012.06.005","article-title":"Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties","volume":"320","author":"Liu","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbrc.2026.154014_bib16","series-title":"Dipyridamole, Statpearls, Treasure Island","author":"Kerndt","year":"2025"},{"key":"10.1016\/j.bbrc.2026.154014_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108851","article-title":"GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase\/c-Jun N-terminal kinase pathway","volume":"703","author":"Yamada","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2026.154014_bib18","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154014_bib19","first-page":"385","volume":"66","author":"Dor","year":"1975"},{"key":"10.1016\/j.bbrc.2026.154014_bib20","first-page":"201","article-title":"Forskolin: a unique diterpene activator of cyclic AMP-generating systems","volume":"7","author":"Seamon","year":"1981","journal-title":"J. Cyclic. Nucl. Res."},{"key":"10.1016\/j.bbrc.2026.154014_bib21","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(19)34116-X","volume":"265","author":"Chijiwa","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154014_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2008.02.006","article-title":"Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-\u03b3 transcription","volume":"201","author":"Park","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2026.154014_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.metabol.2013.09.006","article-title":"The hypolipidemic effect of cilostazol can be mediated by regulation of hepatic low-density lipoprotein receptor-related protein 1 (LRP1) expression","volume":"63","author":"Kim","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.bbrc.2026.154014_bib24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.108.146456","article-title":"Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db\/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription","volume":"329","author":"Park","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrc.2026.154014_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.154014_bib26","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1021\/bi0159581","article-title":"Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662","volume":"41","author":"Leesnitzer","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2026.154014_bib27","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy","volume":"12","author":"Scaltriti","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154014_bib28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154014_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.0001u.x","article-title":"A human peroxisome-proliferator-activated receptor-\u03b3 is activated by inducers of adipogenesis, including thiazolidinedione drugs","volume":"239","author":"Lambe","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154014_bib30","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.2147\/DDDT.S524893","article-title":"Therapeutic targeting of PPAR\u03b3 in nonalcoholic fatty liver disease: efficacy, safety, and drug development","volume":"19","author":"Zhou","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrc.2026.154014_bib31","first-page":"5417","article-title":"Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF-\u03baB\/COX-2\/PPAR-\u03b3 activities","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.154014_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tiv.2017.08.012","article-title":"ONTD induces growth arrest and apoptosis of human hepatoma Bel-7402 cells through a peroxisome proliferator-activated receptor \u03b3-dependent pathway","volume":"45","author":"Tan","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.bbrc.2026.154014_bib33","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0006-291X(02)00385-6","article-title":"PPAR activators inhibit endothelial cell migration by targeting Akt","volume":"293","author":"Goetze","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154014_bib34","article-title":"ASH2L-K312-Lac stimulates angiogenesis in tumors to expedite the malignant progression of hepatocellular carcinoma","volume":"12","author":"Han","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbrc.2026.154014_bib35","article-title":"A tumor microenvironment-derived CAF-VEGF model and its application in biomarker screening for HCC","volume":"44","author":"Zhang","year":"2026","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bbrc.2026.154014_bib36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41418-024-01436-w","article-title":"ABCF1-K430-lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway","volume":"32","author":"Hong","year":"2025","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bbrc.2026.154014_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119912","article-title":"Astragali radix-Curcumae rhizoma herb pair suppresses hepatocellular carcinoma through EGFR\/AKT\/mTOR pathway and induces lipid peroxidation-related ferroptosis via HIF-1\u03b1\/HO-1\/GPX4 axis","volume":"348","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2026.154014_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2020.00460","article-title":"Dandelion polysaccharide exerts anti-angiogenesis effect on hepatocellular carcinoma by regulating VEGF\/HIF-1\u03b1 expression","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154014_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13105-025-01069-8","article-title":"The impact of high altitude (hypobaric hypoxia) on insulin resistance in humans","volume":"81","author":"Adeva-Andany","year":"2025","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2026.154014_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70074","article-title":"Tryptophan suppresses FTH1-driven ferritinophagy, a key correlate of prognosis in hepatocellular carcinoma","volume":"59","author":"Cheng","year":"2026","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrc.2026.154014_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/nyas.70224","article-title":"The TRIB1-PPAR\u03b3 axis regulates cholesterol metabolism in pancreatic ductal adenocarcinoma","volume":"1557","author":"Sun","year":"2026","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbrc.2026.154014_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117089","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC)","volume":"177","author":"Pan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.154014_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s40001-023-01275-4","article-title":"Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects","volume":"28","author":"Mohi-ud-din","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.bbrc.2026.154014_bib44","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.2147\/DDDT.S86845","article-title":"Pharmacokinetic comparison of sustained- and immediate-release formulations of cilostazol after multiple oral doses in fed healthy male Korean volunteers","volume":"9","author":"Kim","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2026.154014_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-199937002-00002","article-title":"Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics","volume":"37","author":"Bramer","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2026.154014_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-199937002-00007","article-title":"Effects of CYP3A inhibition on the metabolism of cilostazol","volume":"37","author":"Suri","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbrc.2026.154014_bib47","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/01.STR.0000179044.37760.9d","article-title":"Role of adenosine and nitric oxide on the mechanisms of action of dipyridamole","volume":"36","author":"Gamboa","year":"2005","journal-title":"Stroke"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:00:51Z","timestamp":1783148451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26007783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"alternative-id":["S0006291X26007783"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154014","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cilostazol inhibits TGF-\u03b1-induced migration of hepatocellular carcinoma cells by activating PPAR\u03b3","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154014"}}